Epicardial Fat and Atrial Fibrillation: the Role of Profibrinogenic Mediators

Background. Epicardial adipose tissue (EAT) has certain paracrine functions, which could be associated with proinflammatory and fibrotic changes in myocardium even in patients without structural heart disease but with atrial fibrillation (AF). Purpose: to evaluate interrelationship between clinical data, parameters of tissue Doppler imaging (TDI), EAT thickness estimated by magnetic resonance imaging (MRI), and biochemical markers of fibrosis and inflammation in patients with nonvalvular AF without concomitant ischemic heart disease (IHD). Materials and Methods. We included in this study 39 AF patients without valvular pathology or IHD with normal or moderately increased left atrial (LA) dimension (mean age 50.8±13.9 years, 49% men). The following groups were distinguished for analysis: with idiopathic AF (iAFgroup, n=21); with AF and arterial hypertension (AF+AH group, n=18); with normal (<4.5cm) (n=29), and with slightly enlarged (>4.5cm) LA dimensions (n=10). Besides standard ECG and echocardiography (ECHO), all patients underwent TDI and cardiac MRI with late gadolinium enhancement (LGE). Periventricular EAT thickness and LA fibrosis were calculated by MRI. Examination also included measurement of levels of matrix metalloproteinases (MMP-2, MMP-9), tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), transforming growth factor β₁ (TGF-β₁), and soluble intercellular adhesion molecule (sICAM). Results. Most close correlations were found between EAT thickness and levels of the following biomarkers were found to closest: MMP-9 (τ=0.65; Tcr=0,16), TIMP-1 (τ=0,71; Tcr=0,18) in iAF group; and TGF-β₁ (τ=0.22; Tcr=0.19) in the whole group. The LA fibrosis (%) was associated with TIMP-1 with strongest correlation in iAF group (τ=0.72; Tcr 0.21). Myocardial mass was significantly associated with TGF-β₁ in the group with LA<4.5cm (τ=0.92, Tcr 0.14), and with LA>4.5cm (τ=0.81, Tcr 0.24). E/e’ by TDI correlated with levels of MMP-9 and TIMP-1 (τ=0.65, Tcr=0.16, and τ=0.56, Tcr=0.21, respectively), and with TGF-β₁ being closest in the group with LA <4.5 cm (τ=0,57; Tcr 0,14). Among clinical factors body mass was slightly associated with EAT (τ=0.33, Tcr=0.26). Conclusion. The EAT and LA fibrosis by LGE MRI is significantly associated with markers of fibrosis (MMP-9, TIMP-1, TGF-β₁ in patients with AF without structural heart disease. Elevation of MMP-9 and TIMP-1 levels are associated with LV diastolic dysfunction in these patients, what can reflect initial signs of atrial cardiomyopathy even in patients with nonvalvular “nonischemic” AF with normal or slightly enlarged LA.

эпикардиальный жир, фибрилляция предсердий, маркеры фиброза миокарда, магнитно-резонансная томография, epicardial fat, atrial fibrillation, myocardial fibrosis markers, magnetic resonance tomography

1. Fabritz L., Guasch E., Antoniades C. et al. Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nature Revi Cardiol 2016;13:230-237.

2. Wong Ch., Ganesan A., Selvanaygam J. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications and future directions. Eur Heart J. 2016, doi:10.1093/eurheartj/ehw045.

3. Wong C. X., Sullivan T., Sun M. T. et al. Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation: A Meta-Analysis of 626,603 Individuals in 51 Studies. JACC: clinical electrophysiology 2015;3:139-152.

4. Lee J.J., Yin X., Hoffmann U. et al. Relation of pericardial fat, intrathoracic fat, and abdominal visceral fat with incident atrial fibrillation (from the Framingham Heart Study). Am J. Cardiol 2016;118 (10):1486-1492.http://dx.doi.org/10.1016/j. amjcard. 2016.08.011.

5. Latchamsetty R., Morady F. Catheter Ablation of Atrial Fibrillation. Heart Failure Clinics 2016;12 (2):223-233.

6. Goette A., Kalman J. M., Aguinaga L. et al. EH^A/HRS/APHRS / SOLAECE expert consensus on Atrial cardiomyopathies: definition, characterization, and clinical implication. Europace 2016. doi:10.1093/europace/euw161.

7. Жолбаева А. З., Табина А. Е., Голухова Е. З. Молекулярные механизмы фибрилляции предсердий: в поиске «идеального» маркера. Креативная кардиология 2015;2:40-53

8. Haemers P., Hamdi H., Guedj K. Atrial fibrillation is associated with the fibrotic remodeling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J. 2017;38:53-56.

9. Venteclef N., Guglielmi V., Balse E. et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 2015;36 (13):795-805.

10. Mookadam F., Goel R., Alharthi M. S. et al. Epicardial fat and its association with cardiovascular risk: a cross-sectional observational study. Heart Views 2010;11 (3):103-108.

11. Wong C. X., Abed H. S., Molaee P. et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J. Am Coll Cardiol 2011;57:1745-1751.

12. Thanassoulis G., Massaro J. M., O'Donnell CJ. et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart study. Circ Arrhythm Electrophysiol 2010;3:345e350.

13. Tereshenko L., Rizzi P., Newton N. et al. Infiltrated atrial fat characterizes underlying atrial fibrillation substrate in patients at risk as defined by ARIC atrial fibrillation risk score. Int J. Cardiol 2014;172:196-201.

14. Mukherjee R., Akar J. G., Wharton J. M. et al. Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metallo-proteinases predict recurrence of atrial fibrillation following cardioversion. J. Cardiovasc Transl Res 2013;6 (4):528-535.

15. Rosenberg M. A., Maziarz M., Tan A. Y. et al. Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS). Am Heart J. 2014;167 (5):723-728.

16. Boixel С., Fontaine V., Rucker-Martin C. et al. Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat J. Am Coll Cardiol 2003;42:336-344.